BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 34896929)

  • 1. Nucleus basalis of Meynert predicts cognition after deep brain stimulation in Parkinson's disease.
    Kübler D; Wellmann SK; Kaminski J; Skowronek C; Schneider GH; Neumann WJ; Ritter K; Kühn A
    Parkinsonism Relat Disord; 2022 Jan; 94():89-95. PubMed ID: 34896929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nucleus basalis of Meynert neuronal activity in Parkinson's disease.
    Lee DJ; Milosevic L; Gramer R; Sasikumar S; Al-Ozzi TM; De Vloo P; Dallapiazza RF; Elias GJB; Cohn M; Kalia SK; Hutchison WD; Fasano A; Lozano AM
    J Neurosurg; 2019 Feb; 132(2):574-582. PubMed ID: 30797189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined subthalamic and nucleus basalis of Meynert deep brain stimulation for Parkinson's disease with dementia (DEMPARK-DBS): protocol of a randomized, sham-controlled trial.
    Daniels C; Steigerwald F; Capetian P; Matthies C; Malzahn U; Heuschmann PU; Volkmann J
    Neurol Res Pract; 2020; 2():41. PubMed ID: 33324941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bilateral Deep Brain Stimulation of the Nucleus Basalis of Meynert for Parkinson Disease Dementia: A Randomized Clinical Trial.
    Gratwicke J; Zrinzo L; Kahan J; Peters A; Beigi M; Akram H; Hyam J; Oswal A; Day B; Mancini L; Thornton J; Yousry T; Limousin P; Hariz M; Jahanshahi M; Foltynie T
    JAMA Neurol; 2018 Feb; 75(2):169-178. PubMed ID: 29255885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-Trajectory Multiple-Target Deep Brain Stimulation for Parkinsonian Mobility and Cognition.
    Sasikumar S; Cohn M; Harmsen IE; Loh A; Cho SS; Sáenz-Farret M; Maciel R; Soh D; Boutet A; Germann J; Elias G; Youm A; Duncan K; Rowland NC; Strafella AP; Kalia SK; Lozano AM; Fasano A
    Mov Disord; 2022 Mar; 37(3):635-640. PubMed ID: 34806782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gait variability is linked to the atrophy of the Nucleus Basalis of Meynert and is resistant to STN DBS in Parkinson's disease.
    Wilkins KB; Parker JE; Bronte-Stewart HM
    Neurobiol Dis; 2020 Dec; 146():105134. PubMed ID: 33045357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo cholinergic basal forebrain atrophy predicts cognitive decline in de novo Parkinson's disease.
    Ray NJ; Bradburn S; Murgatroyd C; Toseeb U; Mir P; Kountouriotis GK; Teipel SJ; Grothe MJ
    Brain; 2018 Jan; 141(1):165-176. PubMed ID: 29228203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serendipitous Stimulation of Nucleus Basalis of Meynert-The Effect of Unintentional, Long-Term High-Frequency Stimulation on Cognition in Parkinson's Disease.
    Bogdan ID; Oterdoom DLM; van Laar T; Huitema RB; Odekerken VJ; Boel JA; de Bie RMA; van Dijk JMC; On Behalf Of The Nstaps Study Group
    J Clin Med; 2022 Jan; 11(2):. PubMed ID: 35054031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in Nutritional Status after Deep Brain Stimulation of the Nucleus Basalis of Meynert in Alzheimer's Disease--Results of a Phase I Study.
    Noreik M; Kuhn J; Hardenacke K; Lenartz D; Bauer A; Bührle CP; Häussermann P; Hellmich M; Klosterkötter J; Wiltfang J; Maarouf M; Freund HJ; Visser-Vandewalle V; Sturm V; Schulz RJ
    J Nutr Health Aging; 2015 Oct; 19(8):812-8. PubMed ID: 26412285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrity of the nucleus basalis of meynert and self-reported cognitive dysfunction during wearing-off periods in parkinson's disease.
    Lench DH; Turner TH; Wetmore E; Rodriguez-Porcel FJ; Revuelta GJ
    Brain Imaging Behav; 2024 Feb; 18(1):256-261. PubMed ID: 37889445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nucleus basalis of Meynert damage and cognition in patients with multiple sclerosis.
    Hildesheim FE; Benedict RHB; Zivadinov R; Dwyer MG; Fuchs T; Jakimovski D; Weinstock-Guttman B; Bergsland N
    J Neurol; 2021 Dec; 268(12):4796-4808. PubMed ID: 33997915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nucleus basalis of Meynert degeneration precedes and predicts cognitive impairment in Parkinson's disease.
    Schulz J; Pagano G; Fernández Bonfante JA; Wilson H; Politis M
    Brain; 2018 May; 141(5):1501-1516. PubMed ID: 29701787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rethinking NBM DBS: Intermittent stimulation improves sustained attention in Parkinson's disease.
    Sasikumar S; Cohn M; Youm A; Duncan K; Boogers A; Strafella AP; Blake DT; Fasano A
    Brain Stimul; 2023; 16(6):1643-1645. PubMed ID: 37935282
    [No Abstract]   [Full Text] [Related]  

  • 14. Bilateral nucleus basalis of Meynert deep brain stimulation for dementia with Lewy bodies: A randomised clinical trial.
    Gratwicke J; Zrinzo L; Kahan J; Peters A; Brechany U; McNichol A; Beigi M; Akram H; Hyam J; Oswal A; Day B; Mancini L; Thornton J; Yousry T; Crutch SJ; Taylor JP; McKeith I; Rochester L; Schott JM; Limousin P; Burn D; Rossor MN; Hariz M; Jahanshahi M; Foltynie T
    Brain Stimul; 2020; 13(4):1031-1039. PubMed ID: 32334074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nucleus Basalis of Meynert Stimulation for Lewy Body Dementia: A Phase I Randomized Clinical Trial.
    Maltête D; Wallon D; Bourilhon J; Lefaucheur R; Danaila T; Thobois S; Defebvre L; Dujardin K; Houeto JL; Godefroy O; Krystkowiak P; Martinaud O; Gillibert A; Chastan M; Vera P; Hannequin D; Welter ML; Derrey S
    Neurology; 2021 Feb; 96(5):e684-e697. PubMed ID: 33199437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relation of lead trajectory and electrode position to neuropsychological outcomes of subthalamic neurostimulation in Parkinson's disease: results from a randomized trial.
    Witt K; Granert O; Daniels C; Volkmann J; Falk D; van Eimeren T; Deuschl G
    Brain; 2013 Jul; 136(Pt 7):2109-19. PubMed ID: 23801735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nucleus basalis of Meynert predicts cognitive changes in isolated REM sleep behavior disorder.
    Yang A; Li G
    Sleep Med; 2023 Sep; 109():11-17. PubMed ID: 37393717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longterm outcome of cognition, affective state, and quality of life following subthalamic deep brain stimulation in Parkinson's disease.
    Gruber D; Calmbach L; Kühn AA; Krause P; Kopp UA; Schneider GH; Kupsch A
    J Neural Transm (Vienna); 2019 Mar; 126(3):309-318. PubMed ID: 30684055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nucleus basalis of Meynert degeneration predicts cognitive impairment in Parkinson's disease.
    Wilson H; de Natale ER; Politis M
    Handb Clin Neurol; 2021; 179():189-205. PubMed ID: 34225962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simultaneous Stimulation of the Globus Pallidus Interna and the Nucleus Basalis of Meynert in the Parkinson-Dementia Syndrome.
    Nombela C; Lozano A; Villanueva C; Barcia JA
    Dement Geriatr Cogn Disord; 2019; 47(1-2):19-28. PubMed ID: 30630160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.